Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Treasury Shares (2017 - 2023)

Palisade Bio (PALI) has disclosed Treasury Shares for 9 consecutive years, with $24195.0 as the latest value for Q4 2023.

  • On a quarterly basis, Treasury Shares changed N/A to $24195.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $24195.0, a N/A change, with the full-year FY2023 number at $24195.0, changed N/A from a year prior.
  • Treasury Shares was $24195.0 for Q4 2023 at Palisade Bio, down from $342970.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $342970.0 in Q3 2023 to a low of $1907.0 in Q1 2020.
  • A 4-year average of $76628.2 and a median of $11972.0 in 2019 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: crashed 83.07% in 2020, then skyrocketed 152.6% in 2021.
  • Palisade Bio's Treasury Shares stood at $11972.0 in 2019, then tumbled by 84.07% to $1907.0 in 2020, then skyrocketed by 362.35% to $8817.0 in 2021, then surged by 174.41% to $24195.0 in 2023.
  • Per Business Quant, the three most recent readings for PALI's Treasury Shares are $24195.0 (Q4 2023), $342970.0 (Q3 2023), and $241561.0 (Q2 2023).